And it’s Thursday. It’s Meghana, again, of the Readout — filling in for Ed Silverman this week. Here’s what we got:

Apple’s been working away secretly, for five years, on the “holy grail” for treating diabetes, CNBC reports — a noninvasive glucose monitor. The idea comes straight from Steve Jobs, who conceived it before he died. The device could breathe new life into the Apple Watch, should it actually work.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy